Erasca, Inc. (ERAS)
3.39
+0.13
(+3.99%)
USD |
NASDAQ |
Dec 11, 13:41
Erasca Price: 3.39 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ALX Oncology Holdings, Inc. | 1.53 |
| Prelude Therapeutics, Inc. | 1.62 |
| Atea Pharmaceuticals, Inc. | 3.195 |
| Immuneering Corp. | 6.47 |
| ProKidney Corp. | 2.24 |
Price Related Metrics
| Price to Book Value | 2.765 |
| Earnings Yield | -13.30% |
| Market Cap | 961.78M |